1 x 104 Vero E6 cells were seeded in white μclear 96-well culture plates. After 24 h the cells were incubated with a 2-fold dilution of the cAMP increasing compound forskolin (Cayman chemical) for 30 min at 37°C and cAMP levels were determined with the cAMP-Glo assay (Promega) as per the manufacturer’s instructions. Luminescence was measured in a Mithras LB 940 Multilabel reader (Berthold Technologies). 1.4*105 cells were seeded in 12-well culture plates. After 24 h cells were incubated with a 2-fold dilution of cAMP increasing compounds forskolin. For the cAMP-Glo Assay forskolin had to be diluted in an induction buffer containing two phosphodiesterase inhibitors to prevent cAMP hydrolysis; 500 μM isobutyl-1-methylxanthine (IBMX) (Sigma) and 100 μM Ro 20–1724 (Sigma). Graphpad Prism 8 was used to do a two-tailed non-paired t-tests to determine significant differences. For the WB experiment the 2-fold dilution was started with 5 μM forskolin, 500 μM IBMX and 100 μM Ro 20–1724. Cells were lysed in 4× LSB for WB analysis. An SFV MOI 10 sample 6 h p.i. was included as a positive control.
Assaying ATP and cAMP Levels in Cells
1 x 104 Vero E6 cells were seeded in white μclear 96-well culture plates. After 24 h the cells were incubated with a 2-fold dilution of the cAMP increasing compound forskolin (Cayman chemical) for 30 min at 37°C and cAMP levels were determined with the cAMP-Glo assay (Promega) as per the manufacturer’s instructions. Luminescence was measured in a Mithras LB 940 Multilabel reader (Berthold Technologies). 1.4*105 cells were seeded in 12-well culture plates. After 24 h cells were incubated with a 2-fold dilution of cAMP increasing compounds forskolin. For the cAMP-Glo Assay forskolin had to be diluted in an induction buffer containing two phosphodiesterase inhibitors to prevent cAMP hydrolysis; 500 μM isobutyl-1-methylxanthine (IBMX) (Sigma) and 100 μM Ro 20–1724 (Sigma). Graphpad Prism 8 was used to do a two-tailed non-paired t-tests to determine significant differences. For the WB experiment the 2-fold dilution was started with 5 μM forskolin, 500 μM IBMX and 100 μM Ro 20–1724. Cells were lysed in 4× LSB for WB analysis. An SFV MOI 10 sample 6 h p.i. was included as a positive control.
Corresponding Organization : Netherlands Metabolomics Centre
Variable analysis
- Increasing concentrations of ATP-depleting compounds Antimycin A (Sigma) and 2-deoxy-D-glucose (Sigma)
- 2-fold dilution of the cAMP increasing compound forskolin (Cayman chemical)
- 2-fold dilution of cAMP increasing compounds forskolin, 500 μM isobutyl-1-methylxanthine (IBMX) (Sigma) and 100 μM Ro 20–1724 (Sigma)
- ATP levels
- CAMP levels
- Incubation time: 30 min at 37°C
- Cell lines: 293T and Vero E6
- Culture plates: white μclear 96-well and 12-well
- Assays: CellTiter-Glo 2.0 (Promega) and cAMP-Glo (Promega)
- Luminescence measurement: Mithras LB 940 Multilabel reader (Berthold Technologies)
- SFV MOI 10 sample 6 h p.i.
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!